Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis
US-12497452-B2 · Dec 16, 2025 · US
This page is not indexed by search engines while we improve data quality.
Abb Vie Inc patents
Abb Vie Inc holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 2 |
| First publication | Apr 24, 2018 |
| Latest publication | Dec 16, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis
US-12365729-B2 · Jul 22, 2025 · US
Enzymatic process for the preparation of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acid
US-10316338-B1 · Jun 11, 2019 · US
Spiro-cyclic amine derivatives as S1P modulators
US-9951084-B2 · Apr 24, 2018 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis
US-12497452-B2 · Dec 16, 2025 · US
Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis
US-12365729-B2 · Jul 22, 2025 · US
Enzymatic process for the preparation of (1S,2R)-2-(difluoromethyl)-1-(propoxycarbonyl)cyclopropanecarboxylic acid
US-10316338-B1 · Jun 11, 2019 · US
Spiro-cyclic amine derivatives as S1P modulators
US-9951084-B2 · Apr 24, 2018 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 4 |
| Human Necessities | 3 |